This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when ...

usually require prolonged HSV prophylaxis (BII). Intravenous acyclovir 250 mg/m 2 or 5 mg/kg every 8 h for 7–10 days is the therapy of choice for severe mucocutaneous or visceral HSV disease (AI).

Mucocutaneous fungal infections are typically found in patients who have no known immune defects. We describe a family in which four women who were affected by either recurrent vulvovaginal ...

GVHD prophylaxis consisted of methotrexate and ... be considered in the differential diagnosis of a single ulcerative mucocutaneous lesion in these immunosuppressed patients.

If you continue to have this issue please contact [email protected]. Back to Healio Mucocutaneous patterns such as ulcers and purpura were commonly observed among individuals ...

This page lists all known medications that could potentially lead to 'Mucocutaneous candidiasis' as a side effect. It's important to note that mild side effects are quite common with medications.

Antimicrobial prophylaxis is an intervention that can reduce the risk of infection in immunosuppressed patients. However, because of drug-related adverse effects as well as concerns with antimicrobial ...

Anifrolumab improves SLE disease activity across musculoskeletal, mucocutaneous and immunological domains, compared with placebo, according to a post-hoc analysis of TULIP-1 and TULIP-2 data ...

Of these, 240 patients received TMP-SMX prophylaxis (prophylaxis group; mean age, 63.7 years; 55.8% women) within 14 days of induction therapy, and 56 patients did not receive prophylaxis (control ...